Key facts
- This page summarizes Deborah Lee Yount's Form 4 filing for AtriCure, Inc. (ATRC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Mar 2025, 17:00.
Deborah Lee Yount - 01 Mar 2025 Form 4 Insider Report for AtriCure, Inc. (ATRC)
- Reporting relationship
- Chief Human Resources Officer
- Issuer ticker
- ATRC
- Reported as of
- 01 Mar 2025
- Net transaction value
- -$463,369
- SEC form
- 4
- Accepted by SEC
- 04 Mar 2025, 17:00:11 UTC
- Prior SEC filing
- 02 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Allison Walker as Attorney-in-fact for Deborah Lee Yount
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Deborah Lee Yount filed Form 4 for AtriCure, Inc. (ATRC) on 04 Mar 2025.
Change
- Previous filing in this sequence was filed on 02 Jul 2024.
- Current net transaction value: -$463,369.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATRC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +14,853
- Change %
- +35%
- Price
- $0.000000
- Shares after
- 57,539
- Date
- 01 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
ATRC
transaction
Common Stock
Tax liability
- Transaction value
- $463,369
- Shares
- -11,961
- Change %
- -21%
- Price
- $38.74
- Shares after
- 45,578
- Date
- 01 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
Footnote F2
The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.